secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2024-09-16T23:59:59+00:00
Accession:  0000950170-24-106817
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics adopts 2024 Inducement Plan, reclassifies director to balance board
--------------------------------------------------------------------------------

- Karah Parschauer reclassified from Class I to Class II director to balance board classes (3 per class).
- Board reduced size to 9 directors; Parschauer's compensation unchanged, remains on Audit Committee.
- Adopted 2024 Inducement Equity Incentive Plan, reserving 1,200,000 shares for new-hire inducement awards.
- Plan intended as material inducement for new employees; no shareholder approval required under Nasdaq rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000095017024106817/0000950170-24-106817-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000095017024106817/tnya-20240912.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-106817

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer